SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bacil Pharma - Quaterly Results

14 Aug 2024 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the June 2024 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -0.33 millions as compared to Net Profit of Rs. 0.17 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -0.33% as compared to 0.18% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.11 0.48 -77.08 0.11 0.48 -77.08 1.31 1.15 13.91
PBIDT -0.33 0.18 -283.33 -0.33 0.18 -283.33 -0.57 -0.99 -42.42
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.33 0.18 -283.33 -0.33 0.18 -283.33 -0.57 -0.99 -42.42
Depreciation 0.00 0.01 0.00 0.00 0.01 0.00 0.02 0.03 -33.33
PBT -0.33 0.17 -294.12 -0.33 0.17 -294.12 -0.59 -1.02 -42.16
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.33 0.17 -294.12 -0.33 0.17 -294.12 -0.59 -1.02 -42.16
Equity 58.90 58.90 0.00 58.90 58.90 0.00 58.90 58.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bacil Pharma Share Price

54.99 -0.69 (-1.24%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×